|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|
| Non-current assets | |||||||||
| Property and equipment | |||||||||
| Right-of-use assets | |||||||||
| Intangible assets | |||||||||
| Other assets | |||||||||
| Financial assets | |||||||||
| Total non-current assets | |||||||||
| Current assets | |||||||||
| Other assets | |||||||||
| Inventories | |||||||||
| Current other assets | |||||||||
| Other assets from government grants and research allowance | |||||||||
| Tax receivable | |||||||||
| Other financial assets | |||||||||
| Financial assets from government grants | |||||||||
| Financial assets | |||||||||
| Cash and cash equivalents | |||||||||
| Total current assets | |||||||||
| TOTAL ASSETS | |||||||||
| Equity | |||||||||
| Issued capital | |||||||||
| Share premium | |||||||||
| Other capital reserves | |||||||||
| Accumulated deficit | |||||||||
| Other components of equity | |||||||||
| Total equity | |||||||||
| Non-current liabilities | |||||||||
| Lease liabilities | |||||||||
| Other liabilities | |||||||||
| Total non-current liabilities | |||||||||
| Current liabilities | |||||||||
| Trade and other payables | |||||||||
| Lease liabilities | |||||||||
| Employee benefits | |||||||||
| Liabilities to warrant holders | |||||||||
| Other liabilities | |||||||||
| Total current liabilities | |||||||||
| Total liabilities | |||||||||
| TOTAL EQUITY AND LIABILITIES | |||||||||
Loading...
